Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.880,06
1,58%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ NeuroOne Medical Technologies Corporation (NMTC) NeuroOne Medical Technologies Corporation (NMTC) Notizie

NeuroOne Medical Technologies Corporation

NMTC
1,1899
-0,0201 (-1,66%)
04 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
10/4/202415:00GLOBENeuroOne® CEO Dave Rosa Featured on Bloomberg Technology
09/4/202415:05GLOBENeuroOne® Announces First Implant of OneRF™ Ablation..
04/4/202415:00GLOBENeuroOne® CEO Dave Rosa Featured on Fox Business Network’s..
26/3/202414:00GLOBENeuroOne® Initiates Limited Commercial Launch of OneRF™..
08/3/202418:00GLOBENeuroOne® to Participate in the 36th Annual Roth Conference
04/3/202420:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202420:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202419:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202423:10GLOBENeuroOne Reports Inducement Grant Under Nasdaq Listing Rule..
21/2/202417:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202416:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202416:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202416:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202422:15EDGAR2Form 8-K - Current report
13/2/202422:00GLOBENeuroOne® Reports First Quarter Fiscal Year 2024 Financial..
08/2/202421:30GLOBENeuroOne® to Report First Quarter Fiscal Year 2024 Financial..
01/2/202419:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202419:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202419:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:09EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/1/202415:02EDGAR2Form ARS - Annual Report to Security Holders
29/1/202415:00EDGAR2Form DEF 14A - Other definitive proxy statements
05/1/202422:16EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
03/1/202419:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202419:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202419:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202300:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202322:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202322:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202315:35EDGAR2Form 144 - Report of proposed sale of securities
15/12/202322:45EDGAR2Form S-8 - Securities to be offered to employees in employee..
15/12/202322:39EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
14/12/202322:30EDGAR2Form 8-K - Current report
14/12/202322:15GLOBENeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year..
11/12/202314:15EDGAR2Form 8-K - Current report
11/12/202314:00GLOBENeuroOne® Receives FDA 510(k) Clearance to Market its OneRF™..
07/12/202322:30GLOBENeuroOne® to Report Fourth Quarter and Fiscal Year 2023..
04/12/202322:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202322:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202322:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202322:55EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
16/11/202314:00EDGAR2Form 8-K - Current report
16/11/202314:00GLOBENeuroOne® Announces Patent Allowance for Drug Delivery..
14/11/202323:15GLOBENeuroOne® Appoints Medtech Executive Christopher R. Volker..
14/11/202300:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202323:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202323:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202323:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202314:15EDGAR2Form 8-K - Current report
07/11/202314:00GLOBENeuroOne® Provides Progress Update on FDA 510(k) Submission..
Apertura: 1,23 Min: 1,15 Max: 1,231
Chiusura: 1,21

La tua Cronologia

NASDAQ
NMTC
NeuroOne Medical Technol...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network